391 related articles for article (PubMed ID: 15084244)
1. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.
Bernstein JL; Langholz B; Haile RW; Bernstein L; Thomas DC; Stovall M; Malone KE; Lynch CF; Olsen JH; Anton-Culver H; Shore RE; Boice JD; Berkowitz GS; Gatti RA; Teitelbaum SL; Smith SA; Rosenstein BS; Børresen-Dale AL; Concannon P; Thompson WD;
Breast Cancer Res; 2004; 6(3):R199-214. PubMed ID: 15084244
[TBL] [Abstract][Full Text] [Related]
2. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P;
J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132
[TBL] [Abstract][Full Text] [Related]
3. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.
Broeks A; Braaf LM; Huseinovic A; Nooijen A; Urbanus J; Hogervorst FB; Schmidt MK; Klijn JG; Russell NS; Van Leeuwen FE; Van 't Veer LJ
Breast Cancer Res; 2007; 9(2):R26. PubMed ID: 17428320
[TBL] [Abstract][Full Text] [Related]
4. Multi-center screening of mutations in the ATM gene among women with breast cancer - the WECARE Study.
Berstein JL; Concannon P; Langholz B; Thompson WD; Bernstein L; Stovall M; Thomas DC;
Radiat Res; 2005 Jun; 163(6):698-9. PubMed ID: 16044499
[No Abstract] [Full Text] [Related]
5. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
[TBL] [Abstract][Full Text] [Related]
6. Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Brooks JD; Teraoka SN; Reiner AS; Satagopan JM; Bernstein L; Thomas DC; Capanu M; Stovall M; Smith SA; Wei S; Shore RE; Boice JD; Lynch CF; Mellemkjaer L; Malone KE; Liang X; ; Haile RW; Concannon P; Bernstein JL
Hum Mutat; 2012 Jan; 33(1):158-64. PubMed ID: 21898661
[TBL] [Abstract][Full Text] [Related]
7. Contralateral second breast cancers: prediction and prevention.
Brenner DJ
J Natl Cancer Inst; 2010 Apr; 102(7):444-5. PubMed ID: 20305130
[No Abstract] [Full Text] [Related]
8. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
Concannon P; Haile RW; Børresen-Dale AL; Rosenstein BS; Gatti RA; Teraoka SN; Diep TA; Jansen L; Atencio DP; Langholz B; Capanu M; Liang X; Begg CB; Thomas DC; Bernstein L; Olsen JH; Malone KE; Lynch CF; Anton-Culver H; Bernstein JL;
Cancer Res; 2008 Aug; 68(16):6486-91. PubMed ID: 18701470
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
[TBL] [Abstract][Full Text] [Related]
10. Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
Reiner AS; Robson ME; Mellemkjær L; Tischkowitz M; John EM; Lynch CF; Brooks JD; Boice JD; Knight JA; Teraoka SN; Liang X; Woods M; Shen R; Shore RE; Stram DO; Thomas DC; Malone KE; Bernstein L; Riaz N; Woodward W; Powell S; Goldgar D; Concannon P; ; Bernstein JL
J Natl Cancer Inst; 2020 Dec; 112(12):1275-1279. PubMed ID: 32119081
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor.
Shafman TD; Levitz S; Nixon AJ; Gibans LA; Nichols KE; Bell DW; Ishioka C; Isselbacher KJ; Gelman R; Garber J; Harris JR; Haber DA
Genes Chromosomes Cancer; 2000 Feb; 27(2):124-9. PubMed ID: 10612799
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy and risk of contralateral breast cancer.
Storm HH; Andersson M; Boice JD; Blettner M; Stovall M; Mouridsen HT; Dombernowsky P; Rose C; Jacobsen A; Pedersen M
J Natl Cancer Inst; 1992 Aug; 84(16):1245-50. PubMed ID: 1640483
[TBL] [Abstract][Full Text] [Related]
13. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.
Kreiss Y; Barak F; Baruch RG; Levy-Lahad E; Pras E; Friedman E
Genet Test; 2000; 4(4):403-7. PubMed ID: 11216667
[TBL] [Abstract][Full Text] [Related]
14. ATM, radiation, and the risk of second primary breast cancer.
Bernstein JL; ; Concannon P
Int J Radiat Biol; 2017 Oct; 93(10):1121-1127. PubMed ID: 28627265
[TBL] [Abstract][Full Text] [Related]
15. Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk.
Kaufmann WK; Filatov L; Oglesbee SE; Simpson DA; Lotano MA; McKeen HD; Sawyer LR; Moore DT; Millikan RC; Cordeiro-Stone M; Carey LA
Carcinogenesis; 2006 Dec; 27(12):2519-27. PubMed ID: 16777992
[TBL] [Abstract][Full Text] [Related]
16. Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer.
Watt GP; Reiner AS; Smith SA; Stram DO; Capanu M; Malone KE; Lynch CF; John EM; Knight JA; Mellemkjær L; Bernstein L; Brooks JD; Woods M; Liang X; Haile RW; Riaz N; Conti DV; Robson M; Duggan D; Boice JD; Shore RE; Tischkowitz M; Orlow I; Thomas DC; Concannon P; Bernstein JL
JAMA Netw Open; 2019 Sep; 2(9):e1912259. PubMed ID: 31560388
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy in the treatment of hereditary breast cancer.
Pierce LJ; Haffty BG
Semin Radiat Oncol; 2011 Jan; 21(1):43-50. PubMed ID: 21134653
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer.
Xia F; Powell SN
Semin Radiat Oncol; 2002 Oct; 12(4):296-304. PubMed ID: 12382188
[TBL] [Abstract][Full Text] [Related]
19. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.
Bernstein JL; Teraoka S; Southey MC; Jenkins MA; Andrulis IL; Knight JA; John EM; Lapinski R; Wolitzer AL; Whittemore AS; West D; Seminara D; Olson ER; Spurdle AB; Chenevix-Trench G; Giles GG; Hopper JL; Concannon P
Hum Mutat; 2006 Nov; 27(11):1122-8. PubMed ID: 16958054
[TBL] [Abstract][Full Text] [Related]
20. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study.
Brooks JD; Boice JD; Stovall M; Reiner AS; Bernstein L; John EM; Lynch CF; Mellemkjær L; Knight JA; Thomas DC; Haile RW; Smith SA; Capanu M; Bernstein JL; Shore RE;
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):917-24. PubMed ID: 22483700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
